Telix Pharmaceuticals Announces Licence Agreement with Lilly for Olaratumab ...Middle East

PR Newswire - News
Telix Pharmaceuticals Announces Licence Agreement with Lilly for Olaratumab
MELBOURNE, Australia and INDIANAPOLIS, April 10, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, "Telix", the "Company") today announces that it has entered into a licence agreement with Eli Lilly and Company ("Lilly") under which Telix is granted exclusive worldwide rights...

Hence then, the article about telix pharmaceuticals announces licence agreement with lilly for olaratumab was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Telix Pharmaceuticals Announces Licence Agreement with Lilly for Olaratumab )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News